Xiamen Eagledon Pharmaceutical Co., Ltd.

Eagledon Pharmaceutical is a wholly-owned subsidiary of Australia Eagle Health Holdings Ltd. Founded in 2001, it is a comprehensive ecological pharmaceutical enterprise focusing on the research and development, production and sales of pharmaceuticals, health products, nutritional products and dietary supplements. Intellectual property superior enterprises and national high-tech enterprises have 126 national patents, including 80 invention patents and 46 registered trademarks with 30,000 square meters of its own plant, 100,000-level air purification GMP production workshop, 2000-square-meter GMP health product production workshops. It has undertaken a number of national spark plans and provincial (municipal) technology projects . 50,000 acres of Chinese medicinal materials under the forest imitation wild planting base, focusing on research and development and production of high-end health nutrition products. Beginning at the end of 2019, the strategic transformation to the second-class device industry began. In March 2020, it was included in the list of the first batch of key medical material production enterprises by Chinese Municipal Government. The company started its foreign trade business since 2009, nearly 50% of the products are exported to Europe, Australia and US, the annual sales reached 5 million US dollars, the products with international certifications such as QKR and CE are exported to UK, france and USA.